INTRODUCTION
Schwann cells are the principal glial cells of the vertebrate peripheral nervous system (PNS), where they either synthesize a myelin sheath around a single larger diameter (.1 µm) axon or invest and support multiple smaller caliber axons. Myelinating and nonmyelinating Schwann cells are distinguished by a number of wellstudied morphological and molecular properties (for reviews, see Lemke, 1992; Mirsky and Jessen, 1996) . The former associate with axons in a 1:1 relationship, elaborate the myelin sheath, and express myelin-specific genes such as those encoding myelin Protein Zero (P 0 ) and myelin basic protein (MBP). In contrast, nonmyelinating Schwann cells associate with multiple small diameter axons and express no myelin-specific genes; instead, they express markers such as the p 75 low-affinity nerve growth factor receptor (LNGF-R) and glial fibrillary acidic protein (GFAP). All Schwann cells are derived from a common neural crest lineage, and all express the cytoskeletal marker S-100b after transiting from a ''precursor'' to an immature Schwann cell phenotype, which occurs around Embryonic Day 16 (E16) in rat sciatic nerve (Jessen et al., 1994) . The subsequent final regulation of myelinating versus nonmyelinating Schwann cell fates is determined by the axons with which immature Schwann cells find themselves in contact (Aguayo et al., 1976; Lemke and Chao, 1988; Voyvodic, 1989) .
In developing myelinated peripheral nerves, immature Schwann cells are generally segregated into premyelinating and promyelinating stages of differentiation, based on morphological criteria (for a review, see Webster and Favilla, 1984) . As ''premyelinating'' Schwann cells divide and migrate along axonal bundles during embryonic development, they are seen to first loosely ensheath and then progressively segregate clusters of axons from one another with cytoplasmic pro-cesses. Subsequently, ''promyelinating'' Schwann cells exit the cell cycle and ensheath only a single axon before the onset of myelination. Nonmyelinating Schwann cells, in contrast, continue to invest multiple axons throughout development, with each unmyelinated axon eventually becoming separated from its neighbors by a cuff of Schwann cell cytoplasm.
To date, at least two transcription factors that might regulate these developmental processes have been identified. SCIP (suppressed, cAMP-inducible POU-domain protein, Oct-6/Tst-1) is a POU protein that is transiently induced by axonal contact in Schwann cells in vivo and in vitro (Monuki et al., 1989; Scherer et al., 1994) and is stably induced in cultured Schwann cells by agents that elevate intracellular cAMP (e.g., forskolin; Monuki et al., 1989 Monuki et al., , 1990 . However, SCIP expression is barely detectable in mature sciatic nerves or in Schwann cells cultured in the absence of cAMP-elevating agents. Biochemical analyses of SCIP RNA levels in rodent sciatic nerves during the first 3 weeks after birth are consistent with SCIP expression being largely restricted to late dividing premyelinating and postmitotic promyelinating cells, although this has not been established at the cellular level. Cultured Schwann cells treated with a combination of forskolin and growth factors are both rapidly dividing and strongly SCIP 1 (Monuki et al., 1990) , indicating that SCIP expression and cell division are not mutually exclusive in vitro. The importance of SCIP to peripheral myelination is demonstrated by the observations that expression in mouse Schwann cells of a P 0 -promoter-driven truncation mutant of SCIP (P 0 DSCIP) results in aberrant and premature myelination (Weinstein et al., 1995) , while complete loss-offunction mutations in the mouse SCIP gene result in a significant delay in peripheral myelination (Bermingham et al., 1996) that is eventually overcome (Jaegle et al., 1996) .
Krox-20 (EGR-2) is a zinc finger transcription factor recently reported to be expressed in Schwann cells and to be essential for the elaboration of the peripheral myelin organelle (Topilko et al., 1994) . Mice homozygous for a Krox-20 null mutation are devoid of peripheral myelin and express very little P 0 , but promyelinating Schwann cells in these mice establish a 1:1 relationship with the axons that would normally have been myelinated. Krox-20 is therefore essential for the terminal differentiation of myelinating Schwann cells and, based upon previously reported expression data for SCIP (Monuki et al., 1990; Scherer et al., 1994) , might be temporally and spatially localized with SCIP.
We have carried out a detailed analysis of the regulated expression patterns of SCIP and Krox-20 at the single cell level in three experimental settings and have compared these patterns to those of (a) the LNGF-R, S-100b, and P 0 proteins, which mark distinct stages in Schwann cell differentiation; (b) the proliferative state of Schwann cells; and (c) the presence or absence of axons. In every myelinating tissue examined and in every experimental setting, Schwann cell expression of Krox-20 is detectable only after SCIP has been expressed for at least 24 h. In myelinating Schwann cells, SCIP and Krox-20 are transiently coexpressed for an additional 24-48 h, after which time SCIP is gradually downregulated while Krox-20 is indefinitely maintained. In Schwann cells cultured in the presence of forskolin, an in vitro model of myelinative differentiation, and in nerve regeneration paradigms, the relative expression patterns of SCIP and Krox-20 closely parallel their pattern in normal development. Nonmyelinating Schwann cells and DRG satellite cells also transiently express SCIP during development, but never express Krox-20. Based upon these and previously reported data, we propose a lineage model for Schwann cell differentiation in which SCIP functions at the decision point between alternative Schwann cell fates, while Krox-20 functions later in development as a transactivator of differentiation genes only in Schwann cells that are already committed to myelination.
RESULTS

Generation of a Specific Anti-SCIP Antibody
Our previous attempts to generate polyclonal anti-SCIP antibodies were carried out with immunogens that carried the highly conserved POU domain (Kuhn et al., 1991) and resulted in relatively low-titer sera that exhibited cross-reactivity to certain other members of the POU domain gene family. Consequently, we generated antibodies against bacterially expressed amino acids 3-145 of SCIP (see Materials and Methods), an amino-terminal region that is highly divergent among POU domain proteins (He et al., 1989; Monuki et al., 1989) . Sera from immunized and boosted rabbits were tested by Western blot against both purified antigen and rat Schwann cells treated with forskolin (data not shown) to evaluate the immune response. High-titer sera were then affinity purified to generate a reagent that is highly specific for SCIP in both Western blot and immunohistochemical tests against known areas of expression (e.g., the CA1 region of the hippocampus; data not shown).
SCIP Is First Expressed in the Schwann Cell Lineage in the Dorsal Roots of the Spinal Cord
Double-label immunohistochemistry was initially performed on embryonic rat dorsal roots, since Schwann cells in these nerves are among the first to differentiate during embryogenesis (Niebroj-Dobosz et al., 1980) . SCIP was first detected in the nuclei of LNGF-R 1 S-100 1 Schwann cells in the dorsal root proximal to the spinal cord on E17 (Figs. 1A and 1C) . (Immunoreactivity for both SCIP and Krox-20 was consistently nuclear.) Schwann cell-containing nerves from earlier time points (data not shown) or from regions of the dorsal root more distal to cord at E17 were SCIP 2 (Figs. 1B and 1C) . By E19, SCIP expression had spread distally within the dorsal root (Fig. 1D) , was occasionally coincident with low-level, cytoplasmic P 0 expression (Fig. 1D) , and was always coincident with high level LNGF-R expression. By P1, robust SCIP expression was evident in most spinal root Schwann cells, including those of the ventral roots (Fig. 1E) ; satellite cells of the dorsal root ganglion (DRG) were negative (see below).
Krox-20 Expression Is Developmentally Delayed Relative to SCIP and Is Coincident with High-Level P 0 Expression
Using a high-affinity Krox-20-specific antibody (Herdegen et al., 1993) , we found that this transcription factor exhibited consistently delayed expression compared to SCIP in spinal root Schwann cells-it was first detectable at P1 in dorsal roots, coincident with high-level P 0 expression (Fig. 1F) . Examination of ventral root Schwann cells of the same developmental age where SCIP expression is robust revealed an absence of both Krox-20 and P 0 expression (Fig. 1G) . With advancing age, all myelinating spinal root Schwann cells became Krox-20 1 and by P13 were associated with the stereotypic annular P 0 expression characteristic of myelinated nerves in cross section (Fig. 1H ). Krox-20 expression was never detected in satellite cells or nonmyelinating Schwann cells, as visualized by late postnatal LNGF-R expression (data not shown).
Since SCIP expression in the postnatal sciatic nerve has been previously described (Monuki et al., 1990; Scherer et al., 1994) , we examined longitudinal sections of rat sciatic nerve to assess the relative developmental expression patterns of SCIP and Krox-20 (see Fig. 2 ). As for embryonic expression in the spinal roots, SCIP expression in the sciatic nerve precedes that of and is dynamic. SCIP was first detectable in proximal regions of the nerve (those closer to the spinal cord) on the day of birth (P0), with no expression seen in distal regions at this time. By P1, expression had spread distally and was seen throughout the sciatic nerve by P2. Expression was most robust at P4 and, as previously reported, declined thereafter and was absent in the adult (Scherer et al., 1994) .
In contrast, Krox-20 expression was absent in sciatic nerve Schwann cells on the day of birth (Fig. 2, right) and was not detected in proximal sciatic nerve Schwann cells until P1. As was the case for SCIP, Krox-20 exhibited a spreading expression pattern during development, from proximal to distal, but was delayed by 1 to 2 days relative to SCIP. For example, Krox-20 expression was absent on P2 from distal sciatic nerve when SCIP expression was detectable along the entire length of the nerve (Fig. 2) . However, by P4 Krox-20 expression was seen in the majority of sciatic nerve Schwann cell nuclei. In contrast to SCIP, this pattern of Krox-20 expression was maintained throughout development, into adulthood. These observations were quantified using a nuclear stain (bis-benzamide) in comparison to bright-fieldvisualized SCIP or Krox-20 expression (see Fig. 3 and Materials and Methods).
The above immunohistochemical data were strongly corroborated by a developmental Northern blot of sciatic nerve mRNAs isolated from animals of increasing postnatal age (Fig. 4A) . SCIP mRNA was detectable by Northern blot in sciatic nerve at P0 and at P3 was prominent; by contrast, Krox-20 mRNA on the same blot was not seen at P0 and was first detected at P3. SCIP mRNA expression was subsequently downregulated during the ensuing postnatal week, while Krox-20 mRNA expression was maintained into adulthood.
Nonmyelinating Schwann Cells Transiently Express SCIP but Not Krox-20
We have found that SCIP is also expressed transiently by Schwann cells committed to a nonmyelinating phenotype (Fig. 5) . Starting at the end of the first postnatal week, SCIP expression is detectable in satellite cells of the DRG (Fig. 5A) , which are phenotypically similar to nonmyelinating Schwann cells in peripheral nerves. SCIP is also detectable as late as P20 in nonmyelinated tissue of the DRG (data not shown) and in the predominantly nonmyelinated superior cervical ganglion (SCG) postganglionic nerve ( Fig. 5B ), although by this time its expression is downregulated in the majority of cells. By adulthood, SCIP is not detectable in any myelinated or nonmyelinated Schwann cell population, including the satellite cells of the DRG, the nonmyelinated SCG postganglionic nerve, and the sciatic nerve (data not shown, Fig. 2 ).
Only a small minority of Schwann cells in the sciatic nerve are SCIP 1 during the second week after birth (Figs. 2 and 3). We examined the phenotype of these late SCIP 1 cells by performing double-label immunohistochemistry on P10 sciatic nerve with antibodies to SCIP and LNGF-R. By P10, myelination is proceeding in the majority of sciatic nerve Schwann cells, but a fraction of these cells remain nonmyelinating. SCIP expression was coincident with high-level LNGF-R expression in sciatic nerve Schwann cells stained in the second postnatal week (Fig. 5C ). Since Krox-20 expression is never seen with strong LNGF-R expression, these are likely to be SCIP 1 nonmyelinating Schwann cells. SCIP 1 Schwann cells never express the high levels of P 0 protein seen in the characteristic ring shape of cross sections of mature myelin (Fig. 5D ), suggesting that SCIP expression must be downregulated before a significant degree of myelin wrapping can occur.
SCIP Is Expressed by Dividing Schwann Cells in Vivo
SCIP is expressed by cultured Schwann cells that are actively dividing in the presence of forskolin and polypeptide growth factors (Monuki et al., 1989) . To determine if SCIP 1 Schwann cells can also be dividing in vivo, we performed 5-bromo-28-deoxyuridine (BrdU)/SCIP double-label immunohistochemistry with sciatic nerves from rat pups pulse-injected with BrdU 1 h prior to sacrifice, to acutely label dividing cells. Postnatal Day 3 was chosen as a convenient time point because most sciatic nerve Schwann cells are SCIP 1 at this time. As shown in Fig. 5E , a minority of these SCIP 1 Schwann cells are dividing, demonstrating that SCIP expression is not incompatible with cell division during Schwann cell development.
Forskolin Induces Krox-20 mRNA Expression in Cultured Schwann Cells with Delayed Kinetics Relative to SCIP mRNA
Neonatal Schwann cells cultured in cAMP-elevating agents express many myelin markers such as P 0 and downregulate expression of markers of nonmyelinating Schwann cells such as the LNGF-R (Lemke and Chao, 1988; Monuki et al., 1989 Monuki et al., , 1990 Morgan et al., 1991) . These and other data have led to the hypothesis that cAMP elevation in cultured cells models the transition to a promyelinating Schwann cell phenotype in vivo. SCIP mRNA expression is strongly upregulated in forskolin-treated cultured Schwann cells, within 1 to 3 h after cAMP elevation (Monuki et al., 1989; Fig. 4B) . In contrast, the kinetics of induction of myelin mRNAs (e.g., those encoding P2, MBP, PLP, and P 0 ) are significantly delayed-these mRNAs are upregulated only after ,24 hours of continuous cAMP elevation. Given these observations, we performed a Northern blot analysis of mRNAs isolated from Schwann cells cultured for increasing periods of time in the presence of forskolin and compared expression of the SCIP and Krox-20 mRNAs (Fig. 4B) . A strong Krox-20 mRNA signal was observed in Schwann cells cultured in the continuous presence of 2 µM forskolin for several days (Fig. 4B , lane 1), as was SCIP mRNA. No signal for either Krox-20 or SCIP mRNA was evident in Schwann cells cultured in the absence of forskolin (Fig. 4B , lane 2). When the kinetics of cAMP-mediated Krox-20 induction were compared to those for SCIP (Fig. 4B , lanes 3-9), an initial extremely strong burst of Krox-20 expression was seen almost immediately upon addition of forskolin with fresh media (Fig. 4B, lanes 3 and 4) . However, this initial burst was found to be solely due to the exposure of the cultured cells to fresh serum and was independent of forskolin ( Fig. 4B, lanes 10 and 11) , a finding consistent with the initial identification of Krox-20 as an immediateearly serum-response gene in fibroblasts (Lemaire et al., 1988) . By 24 h after forskolin addition, however, a second forskolin-dependent Krox-20 mRNA signal appeared, which was more evident by 36 h after induction and which subsequently increased with time (Fig. 4B,  lanes 1, 7-9 ). This time course of cAMP-dependent Krox-20 mRNA induction in vitro is essentially identical to that of myelin mRNAs. The delayed cAMP induction of Krox-20 mRNA relative to SCIP mRNA in cultured Schwann cells parallels the relative in vivo time course of developmental expression described above.
SCIP and Krox-20 Expression in the Schwann Cells of Regenerating Nerves Recapitulates Development
Sciatic nerve regeneration after experimental crush is a well-characterized paradigm that closely mimics development in terms of the reciprocal regulation of early versus late Schwann cell genes (for a discussion, see Scherer et al., 1994) . In particular, expression of myelin markers such as P 0 decreases dramatically as a consequence of the axonal degeneration that occurs distal to the crush site, whereas markers of immature and nonmyelinating Schwann cells such as the LNGF-R are reacquired (Scherer and Salzer, 1996; Scherer et al., 1994) . In crushed nerves, axonal degeneration and Schwann cell dedifferentiation are followed by axonal regeneration and Schwann cell redifferentiation, which occurs in a proximal-to-distal direction relative to the crush site. Previous work has shown that SCIP mRNA expression is detectable as a transient ''blip'' at 1-2 days after crush in the Schwann cell population distal to the injury (the region of axonal degeneration; Monuki et al., 1990; Scherer et al., 1994) . During subsequent regeneration, a more substantial upregulation of SCIP mRNA is seen when these Schwann cells are first recontacted by regrowing axons.
We therefore examined SCIP and Krox-20 expression at progressive stages postcrush (Figs. 6 and 7 ) and posttransection (data not shown). Figures 6A and 6B illustrate a regression of Schwann cell phenotype in degenerating sciatic nerve distal to the crush site at 1 day postcrush, where Krox-20 is no longer detectable in distal Schwann cells, and SCIP is barely detectable in a minority of these cells. This transient SCIP expression in both distal crushed and transected nerve Schwann cells is absent by 12 days postprocedure (data not shown), consistent with previously reported SCIP mRNA expression data (Monuki et al., 1990; Scherer et al., 1994) .
Axonal regrowth into the crushed nerve results in reacquired expression of both SCIP and Krox-20 as regeneration proceeds (Fig. 6) , with a concomitant decrease in LNGF-R expression (Fig. 6C) and an increase in P 0 expression (Fig. 6D) . Further regeneration of the nerve results in remyelination, during which time SCIP expression, as in normal development, falls dramatically. Figures 6B, 6D , 6F, 6H, and 6J show that Krox-20 expression in regenerating nerve also follows the expression pattern seen in normal development, in that Krox-20 expression is maintained in every myelinating Schwann cell nucleus and is coincident with highlevel expression of myelin genes such as P 0 (Fig. 6D, 6H , and 6J). By 58 days postcrush, the regenerated nerve resembles a mature adult sciatic nerve in terms of its patterns of gene expression (Figs. 6I and 6J) .
During axonal reinnervation of a crushed nerve segment, it is possible to precisely monitor changes in Schwann cell gene expression relative to the extent of axonal regrowth. Serial longitudinal cryostat sections of 4-day postcrush sciatic nerves were therefore labeled with anti-neurofilament 160 antibody (to visualize regrowing axons) and either anti-SCIP or anti-Krox-20 antibodies (Fig. 7) . As soon as the growing tips of axonal growth cones are seen to contact distal Schwann cells, SCIP expression is strongly upregulated (Fig. 7, distal) . However, in an adjacent section at the same relative position in the regenerating nerve, no specific Krox-20 staining is detected (Fig. 7, distal) . Krox-20 is detectable only in the nuclei of Schwann cells at this time in an area 3-4 mm behind the in-growing NF-labeled growth cones (data not shown, Fig. 7, proximal) , where SCIP expression is also strongly seen (Fig. 7, proximal) . Based upon estimates of the rate of adult peripheral nerve axonal elongation ranging from 2 to 4 mm/day (Black and Lasek, 1979) , the temporal delay in Krox-20 expression induced by axonal regrowth in Schwann cells relative to SCIP expression is 24-48 h.
Northern blot analyses supported these immunohistochemical data (Fig. 8) . In adult sciatic nerves that had been transected to cause permanent axotomy, the level of Krox-20 mRNA distal to the lesion fell by 4 days and did not return even after 58 days (Fig. 8) . In crushed nerves, the level of Krox-20 mRNA distal to the lesion fell in a similar time course, but returned to nearly normal levels as regeneration proceeded. This was seen in the proximal segment of the distal nerve-stump (D1) at 24 days postlesion and in the distal segment of the distal nerve-stump (D2) at 58 days postlesion (Fig. 8 ). There was a low level of SCIP mRNA in unlesioned adult sciatic nerve, and the amount increased modestly between 1 and 8 days posttransection (Monuki et al., 1989 (Monuki et al., , 1990 Scherer et al., 1994) . The expression of SCIP mRNA in crushed nerves was more pronounced and had a different time course than in transected nerves: a large increase was first seen in the proximal segment of the distal nerve stump at 8 days and in the distal segment of the distal nerve at 24 days (Scherer et al., 1994) . This temporal-spatial gradient of SCIP mRNA expression in crushed nerves precedes that of Krox-20. The level of P 0 mRNA paralleled that of Krox-20 in the distal nerve-stumps of both transected and crushed nerves and hence was temporally and spatially delayed relative to SCIP mRNA (Fig. 8) . The level of LNGF-R mRNA, in contrast, was essentially the reciprocal to that of P 0 and Krox-20, i.e., low in unlesioned nerves, increasing after transection, and increasing and then falling after crush (Fig. 8) .
DISCUSSION Differential Expression of SCIP and Krox-20
A timeline summary of our data on SCIP and Krox-20 expression in both myelinating and nonmyelinating Schwann cell lineages, relative to early (LNGF-R) and Induction of Krox-20 mRNA by forskolin in cultured Schwann cells is kinetically delayed compared to that of SCIP mRNA. Lanes 1 and 2, total RNA isolated from Schwann cells maintained continuously for several days in either the presence (1) or absence (2) of 2 µM fsk. Lanes 3-9, parallel plates of quiescent Schwann cells maintained without fsk were exposed to fsk (20 µM) at time zero and total RNA was prepared from these cells at the indicated times post fsk addition. Lanes 10 and 11, a control experiment in which parallel plates of quiescent Schwann cells were treated with DME containing fresh serum alone at time zero and total RNA was prepared from these cells at the indicated times post serum change. RNA was analyzed by Northern blot (approximately 10 µg per lane). The blots were successively hybridized with radiolabeled cDNA probes for SCIP (top) and Krox-20 (middle). Exposure times: SCIP (20 h), Krox-20 (60 h). (Bottom) Methylene blue stains of the blots, illustrating the relative levels of 28S and 18S ribosomal RNAs. late (P 0 ) Schwann cell genes, is illustrated in Fig. 9 . There are three salient features of this summary. First, SCIP mRNA and protein expression in developing myelinative Schwann cells precedes expression of Krox-20 mRNA and protein by 24-48 h. It is important to note that this time differential holds for normal development, for cAMP induction in cultured Schwann cells, and for regeneration of the sciatic nerve. In the last instance, Schwann cells once again become SCIP 1 within a few hours after being recontacted by ingrowing axons, but these same cells do not become Krox-20 1 for, on average, another 36 h. Our description of Krox-20 mRNA and protein expression during embryonic rat development differs from previous indirect analyses of Krox-20 gene activation in mouse embryos, in that this earlier work gene activation in dorsal and ventral roots was detected at significantly earlier time points (e.g., E11.5) than we have found. Although part of this observed difference may reflect the slightly advanced neural development of mice relative to rats, it is likely to primarily reflect differences in the actual molecular species detected. Topilko and colleagues (1994) histochemically monitored b-galactosidase activity in mice carrying a lacZ pgk-neo fusion gene inserted into the Krox-20 locus and thereby inferred Krox-20 expression, while we have used cDNA probes and a highly sensitive antibody to examine the appearance of Krox-20 mRNA and protein directly. The exclusive use of Xgal staining to infer the expression of a normal gene transcript in an insertionally disrupted locus has in some instances been shown to be complicated by the activation of lacZ gene expression by strong enhancer elements located within the pgk promoter (used to drive neo gene expression for ES cell selection; see, for example, Abeliovich et al., 1992; Rijli et al., 1994) .
The second important feature of the Fig. 9 timeline is that SCIP expression is transient, whereas Krox-20 expression is stable. Although SCIP and Krox-20 are briefly coexpressed by the same cells in the myelinating Schwann cell lineage, SCIP expression is extinguished as cells myelinate, while Krox-20 expression is maintained. Krox-20 is readily detected in Schwann cell nuclei in the adult sciatic nerve, while SCIP is not.
Finally, SCIP is transiently expressed by immature nonmyelinating Schwann cells, whereas Krox-20 expression is restricted to myelinating cells. Our immunohistochemical analyses of DRG satellite cells and Schwann cells of the predominantly nonmyelinated SCG postganglionic nerve demonstrate that SCIP is transiently expressed during the second and third postnatal weeks of development in Schwann cells of the nonmyelinating lineage. We therefore propose an intermediate state for the development of nonmyelinating Schwann cells-the ''pro-nonmyelinating Schwann cell''-which is differentiated from the ''mature nonmyelinating Schwann cell'' by SCIP expression. We have used the expression data in the time line of Fig. 9 , together with other data previously published by us and others, to construct a hypothetical model for distinct stages of cellular differentiation in both the myelinating and the nonmyelinating Schwann cell lineages (Fig. 10 ).
Differential Roles of SCIP and Krox-20
By most standard criteria-including expression in normal development, in regenerating sciatic nerves, and in Schwann cells induced to differentiate in cultureKrox-20 is a conventional myelination gene. We therefore suggest that this regulator serves as a direct transactivator of one or more end-stage genes required for terminal differentiation in the myelinating lineage, particularly in actively myelinating Schwann cells that have become SCIP 2 . Such a role is similar to the hypothesized function of Krox-20 as a transactivator in other cell lineages in which it is expressed, including neurons of the developing hindbrain (Sham et al., 1993) and during bone morphogenesis (Levi et al., 1996) . That Krox-20 participates in the transactivation of myelination genes is strongly supported by the observed peripheral nerve phenotype of Krox-20 mouse knock-outs, in which myelination of axons is permanently blocked at the promyelinating stage that immediately precedes terminal differentiation.
In contrast, the transient role of SCIP is rather more interesting, if also more obscure. It is clear that in the P4 sciatic nerve, the majority of Schwann cells are both SCIP 1 and Krox-20 1 (Fig. 3) . SCIP and Krox-20 are also coexpressed in Schwann cells being reinnervated by axons following nerve crush, for a period of days after the crush. It is therefore possible that during these periods SCIP and Krox-20 may act synergistically to regulate the transition from a promyelinating to a myelinating phenotype. This possibility is in accord with previous demonstrations that POU-domain proteins interact with members of many other transcription
FIG. 8.
Northern blot analysis of normal and lesioned adult rat sciatic nerves. Each lane contains an equal amount (30 µg) of total RNA isolated from the distal stumps of sciatic nerves that had been transected or crushed. The number of days after each of these lesions in indicated; the ''0'' time point is from unlesioned nerves. In crushed nerves, the distal nerve-stumps were divided into proximal (D1) and distal (D2) segments of equal lengths. The blots were successively hybridized with a radiolabeled cDNA probe for Krox-20, SCIP, LNGF-R, glyceraldehyde 3-phosphate dehydrogenase (GAPDH), and P 0 . Exposure times: Krox-20 (2 days), SCIP (5 days), P 0 (2 h), LNGF-R (16 h), and GAPDH (4 days).
FIG. 9.
Schematic summary of the developmental expression patterns of SCIP and Krox-20 in rat Schwann cells.
factor families in the specification of cell fate in other differentiating systems (Bach et al., 1995; Leger et al., 1995; Lichsteiner and Tjian, 1995) .
For 24-48 h prior to its coexpression with Krox-20 in the myelinating Schwann cell lineage, however, and throughout the window of its transient expression in the nonmyelinating lineage, SCIP is expressed in the absence of Krox-20. Schwann cells that lack SCIP are significantly delayed (by ,2 weeks) in the onset of myelination and also appear to stall in the promyelinating stage during the first postnatal week (Bermingham et al., 1996; Jaegle et al., 1996) . In marked contrast to the Krox-20 phenotype, however, SCIP 2/2 Schwann cells are not permanently blocked at this point; they eventually ''catch up'' to wild-type cells, such that by Postnatal Day 90, the peripheral nerves of SCIP mutants (the very small number that survive to this age) are heavily myelinated (Jaegle et al., 1996) . These important differences in the Krox-20 and SCIP mutant phenotypes suggest that SCIP acts before Krox-20 and that stable Krox-20 expression is absolutely required for myelination per se, whereas transient SCIP expression is not. Importantly, they are logically consistent with the differential regulation of these two proteins that we describe above.
The differential activation and regulation of SCIP and Krox-20 also suggest a possible explanation for the curiously differing phenotypes observed in the SCIP knock-out and P 0 DSCIP mice. In the former, SCIP function is inactivated from the beginning of embryogenesis, and myelination is observed to be significantly delayed. In the latter, expression of the ''dominantnegative'' DSCIP truncation mutant occurs later in development (when the P 0 promoter becomes active), and myelination is observed to occur prematurely. If SCIP acts early on, before P 0 and Krox-20 expression, to control entry into the promyelinating transition state that precedes differentiation, then this function would be disrupted in the knock-outs and yield the observed phenotype. However, if SCIP in addition acts later, after P 0 and Krox-20 expression in the myelinating lineage, to repress end-stage myelin gene expression and thereby regulate the onset of myelination, then this second function would be disrupted in the P 0 DSCIP mice and yield their observed phenotype. This ''two-step'' model for SCIP function, as well as several equally valid alternative models, may now be tested through examination of the interaction of the SCIP 2/2 and P 0 DSCIP mutations. 
EXPERIMENTAL METHODS
Cell Culture
Rat Schwann cells were isolated from Postnatal Day 2-3 sciatic nerves, purified by anti-Thy1.1 immunoselection, and cultured in Dulbecco's modified Eagle's medium (DME), 10% fetal calf serum (FCS), forskolin (fsk, 2 µM, Calbiochem), and partially purified bovine GGF, all as described previously (Brockes et al., 1979; Lemke and Brockes, 1984; Porter et al., 1986) . For the generation of quiescent Schwann cells, cultures were washed three times in PBS to remove mitogens and then maintained in DME containing FCS for at least 3 days.
Northern Analyses
Total cellular RNAs from cultured Schwann cells and Sprague-Dawley rat tissues were extracted and analyzed by RNA blot as described previously (Chomczynski and Sacchi, 1987; Scherer et al., 1994; Monuki et al., 1989) . The following cDNAs were used for probes: the 1.7-kb AccI-BamHI fragment of rat Krox-20 (Mack et al., 1992) , the 0.9-kb XhoI-SacII fragment of rat SCIP (Monuki et al., 1989) , the full-length cDNA (2.0 kb) of rat P 0 (Lemke and Axel, 1985) , the 0.7-kb BamHI fragment of rat LNGF-R (Radeke et al., 1987) , and the full-length (1.3-kb) cDNA of rat glyceraldehyde 3-phosphate dehydrogenase (GAPDH; Fort et al., 1985) .
SCIP Antiserum Preparation
The pGEX-2TK vector (Kaelin et al., 1992) was modified to include sites for XbaI, SacI, NcoI, and KpnI by inserting an annealed oligonucleotide composed of the following sequences 58-GATCCTCTAGAGCTCCATGG-TACCCGGG-38, 58-AATTCCCGGGTACCATGGAGCTC-TAGAG-38 into BamHI/EcoRI-digested pGEX-2TK vector to generate pGEX-2TKL. The XbaI-SmaI fragment of pCGS (Monuki et al., 1993a) , coding for amino terminal residues 3-145 of rat SCIP, was then cloned into pGEX-2TKL. Bacterially expressed GST-SCIP3-145 fusion protein was purified using GSH-Sepharose 4B beads (Promega) and cleaved with thrombin according to the manufacturer's instructions (Promega). SCIP3-145 protein was then used to immunize and boost adult NZ white rabbits as described (Thor et al., 1991) . Affinity purification of the antiserum was carried out against purified GST-SCIP3-145 using a QUICKPURE affinity purification kit according to the manufacturer's instructions (Sterogene). Antisera were tested by Western blotting against rat Schwann cell nuclear extracts grown in the presence of forskolin and against purified antigen to determine the specificity of the sera, using previously described techniques (Kuhn et al., 1991) . Depending upon the batch of affinity-purified serum used, the concentration of anti-SCIP primary antibodies used for labeling ranged from 1:400 to 1:2000 for immunoperoxidase staining and from 1:30 to 1:400 for immunofluorescence.
Antibodies
Mouse monoclonal anti-BrdU and anti-NF160 antibodies were obtained from Sigma and used at 1:20 and 1:100 dilutions, respectively. Mouse monoclonal anti-NGF receptor antibodies were obtained from BoehringerMannheim and used at a 1:100 dilution. Mouse monoclonal anti-P 0 antibodies were kindly provided by Dr. J. J. Archelos, at 1:2000. Mouse monoclonal anti-S-100b antibodies (1:300 dilution) were kindly provided by Dr. R. Dyck. Rabbit polyclonal antiserum to Krox-20 (used at 1:3000 for immunoperoxidase and at 1:1000 for immunofluorescence) was a generous gift from Dr. R. Bravo.
Immunohistochemistry
Sprague-Dawley rats were anesthetized and then transcardially perfused with 0.006% lidocaine/0.1 mg/ml heparan sulfate in PBS for 30 s followed by perfusion with 4% paraformaldehyde in PBS for 5 min. Dissected tissues were postfixed in 4% paraformaldehyde/PBS for 2 h at 4°C, followed by overnight infiltration with 20% sucrose in PBS. Sucrose-infiltrated tissues were embedded in O.C.T. medium (Miles), and 4-to 10-µm-thick frozen sections were cut on a cryomicrotome at 220°C, thaw-mounted onto Vectabond-treated glass slides (Vector Laboratories), and dried overnight at room temperature before storage at 270°C. Incubations were performed in 10% normal goat serum/0.1% Triton X-100 (Sigma)/Tris-buffered saline (pH 7.4), and washed between incubations in the same buffer without serum. Sections were typically blocked for 1 h at 25°C and incubated with primary antibodies for 36 h at 4°C. For bright-field microscopy, sections were incubated for 1 h with a biotinylated goat anti-rabbit secondary and then for 45 min with an avidin-biotin-peroxidase complex (Vector Laboratories), followed by a 5-min reaction with 1 mg/ml diaminobenzidine (DAB)/0.03% hydrogen peroxide in PBS. Bright-field samples were then dehydrated in an ethanol series, followed by three rinses in Histo-Clear (National Diagnostics), and then permanently mounted in Accu-Mount 60 (Baxter) mounting medium and coverslipped. For fluorescence micros-copy, immunolabeled sections were incubated for 1 h at 25°C with anti-rabbit/FITC and/or anti-mouse/TRITC secondaries (1:100, Jackson ImmunoResearch). Nuclei were then counterstained with 1 µg/ml bisBenzimide (Hoechst 33258, Sigma) in PBS, and sections were embedded in anti-fade media and coverslipped for storage.
BrdU Injections and Immunohistochemistry
Three-day-old postnatal rat pups were injected ip with BrdU for 1 h before sacrifice following the reasoning and protocol described (Stewart et al., 1993) , in order to label only those Schwann cells in either the S or the G2 phases of the cell cycle. Animals were processed for immunohistochemistry as described above, and cryostat sections were then processed for BrdU labeling as described (Stewart et al., 1993) . After a 1-h incubation with anti-BrdU antibodies, sections were fixed with 4% paraformaldehyde for 5 min and then processed for anti-SCIP staining as above, followed by a double incubation with fluorescent secondaries as above.
Sciatic Nerve Transection and Crush
Using aseptic technique, the sciatic nerves of anesthetized (50 mg/kg pentobarbital ip), adult (10-13 weeks old) Sprague-Dawley rats were exposed at the sciatic notch. Some nerves were doubly ligated, transected with fine scissors, and the two nerve-stumps were sutured at least 1 cm apart. Nerve crush was produced by tightly compressing the sciatic nerve at the sciatic notch with flattened forceps twice, each time for 10 s; this technique causes all of the axons to degenerate, but allows axonal regeneration. At varying times after nerve injury, the animals were sacrificed, the distal nervestumps were removed, and the most proximal 2-3 mm were trimmed off. For transected nerves, the entire distal nerve-stump was taken from just below the lesion to the ankle (about 4 cm long). For crushed nerves, the distal nerve-stump was divided into two equal segments, each about 2 cm long; the most proximal segment was termed distal 1 (D1), and the distal segment was termed D2. The nerves were immediately frozen in liquid nitrogen and stored at 280°C. Unlesioned sciatic nerves were obtained from animals of varying ages, from P0 (the day after birth) to P90.
Imaging
Fluorophore-labeled sections were viewed with a Nikon epifluorescence microscope or with a Bio-Rad MRC 1000 scanning confocal microscope as noted in the figure legends. Epifluorescent images were captured on Kodakchrome 400 color slide film. Slides were then scanned into Adobe Photoshop 3.0.5 (Adobe Systems) using a Polaroid slide scanner. Confocal images were digitally recorded and directly imported into Photoshop.
Quantitative Analysis of Developmental SCIP and Krox-20 Expression in Sciatic Nerve
Serial longitudinal cryostat sections of rat sciatic nerve were stained for SCIP or Krox-20 expression visualized by bright-field microscopy as discussed above, and counterstained with Hoechst to stain all nuclei. Black and white photographs were then taken to cover the entire section by both bright-field and fluorescence for each field. Four bright-field and fluorescent micrographs containing roughly 300 nuclei each were taken for both anti-SCIP and anti-Krox-20 stained sections. Hoechst stained nuclei and bright-field stained nuclei were counted for each field, the fraction of nuclei labeled in each field was calculated, and the data were then compiled using the Deltagraph Pro 3.5 program (Deltapoint, Inc.).
